Next generation sequencing is now a central tool in the analysis of signaling pathways important in development and disease. The Genome Sequencing Core (GSC) is aimed at providing researchers at the University of Kansas in Lawrence with next-generation sequencing technologies as well as expertise in experimental design and analysis of sequence data. Projects in the GSC will include whole genome assembly, genome re-sequencing for identification of mutations important in development and disease, transcriptome analysis (RNA seq), and identification of transcription factor interaction sites using chromatin immunoprecipitation combined with DNA sequencing (ChIP seq). The GSC will house a state-of-the-art lllumina Hiseq 2000 sequencer with dedicated processor and storage space to run the instrument. This core facility will enhance the genomics infrastructure already at KU, in the KU Genomics Center and the KU DNA Sequencing Facility, which provides standard, first generation sequencing. Together, the three cores allow for a thorough, integrated dissection of disease pathways using novel fluorescence probes to define a cellular process, to find mutations affecting that cellular process, and to define genes involved in the cellular process. The novel approach of the MADP is to combine the enabling technologies of fluorescent probe synthetic chemistry and next generation sequencing to set up a pipeline for target discovery in disease pathways. Next generation sequencing is an enabling technology in that it has the power to allow investigators from many different disciplines to ask new questions in their research areas of interest. The GSC will enable genomics research at the University of Kansas by eliminating the barriers of cost and communication involved with using off-campus facilities. Interest in next generation sequencing at the University of Kansas in Lawrence is high, and includes investigators in the Pharmacy School, the Department of Molecular Biosciences, and the Department of Ecology and Evolutionary Biology. Use ofthe GSC will be by Projects in this Molecular Analysis of Disease Pathways COBRE, as well as by researchers across the campus and in many different disciplines.

Public Health Relevance

Next-generation sequencing technologies have revolutionized genetic and molecular analyses by allowing the generation of tens of millions of sequencing reads and billions of sequenced bases in a relatively short time and for a relatively low cost. The uses are many and profound, such as genome re-sequencing to identify new mutations or lesions important in diseases such as cancer;transcriptome analysis to understand global gene regulation in normal and pathogenic states;and global analysis of transcription factor interactions with regulatory elements across the entire genome. Next-generation sequencing is becoming a central tool in almost every aspect of genetic and molecular research, and the Genome Sequencing Core will provide a strong base for next-generation sequencing at the University of Kansas and will serve as a base for continued growth in this area at the university.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Exploratory Grants (P20)
Project #
1P20GM103638-01
Application #
8461770
Study Section
Special Emphasis Panel (ZRR1-RI-B (01))
Project Start
Project End
Budget Start
2012-07-15
Budget End
2013-06-30
Support Year
1
Fiscal Year
2012
Total Cost
$289,344
Indirect Cost
$55,573
Name
University of Kansas Lawrence
Department
Type
DUNS #
076248616
City
Lawrence
State
KS
Country
United States
Zip Code
66045
Eshelman, Kate; Yao, Huili; Punchi Hewage, Achala N D et al. (2017) Inhibiting the BfrB:Bfd interaction in Pseudomonas aeruginosa causes irreversible iron accumulation in bacterioferritin and iron deficiency in the bacterial cytosol. Metallomics 9:646-659
Rusk, Rachel A; Palmer, Mitchell V; Waters, W Ray et al. (2017) Measuring bovine ?? T cell function at the site of Mycobacterium bovis infection. Vet Immunol Immunopathol 193-194:38-49
Waters, Renae; Alam, Perwez; Pacelli, Settimio et al. (2017) Stem cell-inspired secretome-rich injectable hydrogel to repair injured cardiac tissue. Acta Biomater :
Pacelli, Settimio; Basu, Sayantani; Whitlow, Jonathan et al. (2017) Strategies to develop endogenous stem cell-recruiting bioactive materials for tissue repair and regeneration. Adv Drug Deliv Rev 120:50-70
Brawley, Susan H; Blouin, Nicolas A; Ficko-Blean, Elizabeth et al. (2017) Insights into the red algae and eukaryotic evolution from the genome of Porphyra umbilicalis (Bangiophyceae, Rhodophyta). Proc Natl Acad Sci U S A 114:E6361-E6370
Pacelli, Settimio; Maloney, Ryan; Chakravarti, Aparna R et al. (2017) Controlling Adult Stem Cell Behavior Using Nanodiamond-Reinforced Hydrogel: Implication in Bone Regeneration Therapy. Sci Rep 7:6577
Pacelli, Settimio; Acosta, Francisca; Chakravarti, Aparna R et al. (2017) Nanodiamond-based injectable hydrogel for sustained growth factor release: Preparation, characterization and in vitro analysis. Acta Biomater 58:479-491
Sofis, Michael J; Jarmolowicz, David P; Kaplan, Sam V et al. (2017) KU32 prevents 5-fluorouracil induced cognitive impairment. Behav Brain Res 329:186-190
Pes, Romina; Godar, Sean C; Fox, Andrew T et al. (2017) Pramipexole enhances disadvantageous decision-making: Lack of relation to changes in phasic dopamine release. Neuropharmacology 114:77-87
Fowler, Stephen C; Mosher, Laura J; Godar, Sean C et al. (2017) Assessment of gait and sensorimotor deficits in the D1CT-7 mouse model of Tourette syndrome. J Neurosci Methods 292:37-44

Showing the most recent 10 out of 108 publications